- POSITIVE
Annual Revenue Unihealth Consultancy Mar-2026 Annual Revenue is Rs 13 Cr which is growth of 92.6% YoY.
- POSITIVE
Annual Net Profit Unihealth Consultancy Mar-2026 Annual Net Profit is Rs 6 Cr which is growth of 178.2% YoY.
Unihealth Consultancy, established on February 26, 2010, is a healthcare service provider headquartered in Mumbai, India, with operational activities spanning several countries in Africa. The company operates across various business segments, encompassing medical centers, hospitals, consultancy services, distribution of pharmaceutical and medical consumable products, and medical value travel.
| Bidding Dates |
|---|
| 08 Sep 2023 - 12 Sep 2023 |
| Subscription |
|---|
| 22.96x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹132,000 | 1 | 1 | 1000 | 4.3 M | ₹126 - ₹132 | 72.18 % | ₹539.8 M - ₹565.5 M | RHP DOC |
Unihealth Consultancy IPO SUBSCRIPTION STATUS
12 Sep '23Total22.96x
Retail Individual Investor32.66x
HNI (NII) Investors50.42x
Qualified Institutional Buyers7.93x
Unihealth Consultancy IPO overall subscription rate was 22.96 times the total available shares
Unihealth Consultancy IPO retail subscription rate was 32.66 times in the retail segment
Unihealth Consultancy IPO non-institutional investor subscription rate was 50.42 times in the non-institutional investor category
Unihealth Consultancy IPO Qualified Institutional Bidder subscription rate was 7.93 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
12 Sep 2023 (Day 3) | 32.66x | 50.42x | 7.93x |
11 Sep 2023 (Day 2) | 13.64x | 5.36x | 0.06x |
08 Sep 2023 (Day 1) | 3.09x | 0.69x | 0.01x |
Unihealth Consultancy FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| FY23 | 76.8 | 439.4 | 13.3 | -7.7 | 36.2% |
| FY22 | 38.2 | 368.3 | 92.7 | 79.7 | 34.2% |
| FY21 | 50.1 | 262.1 | 40.6 | 37.0 | 34.1% |
Unihealth Consultancy IPO SUBSCRIPTION STATUS DETAILS
Unihealth Consultancy had 4.3 M shares on offer
Unihealth Consultancy IPO offer price was in the range ₹126 - ₹132
Unihealth Consultancy IPO minimum Investment was ₹132000
Unihealth Consultancy IPO issue size was ₹ 539.8 M - ₹ 565.5 M
Unihealth Consultancy had a minimum lot size of 1000 Shares per application
Unihealth Consultancy NUMBER OF SHARES ON OFFER
Total4.3 M
Fresh Issue4.3 M
Offer for Sale0
Post Issue Promoter Holding %72.18 %
Unihealth Consultancy IPO IMPORTANT DATES
| Issue Open Date | 08 Sep 2023 |
| Issue close Date | 12 Sep 2023 |
| Allotment Date | 15 Sep 2023 |
| Refund Date | 18 Sep 2023 |
| Demat Account Credit Date | 20 Sep 2023 |
| Listing Date | 21 Sep 2023 |
| Listing on Exchange(s) | NSE |
| Unihealth Consultancy Allotment Status | Exchange |
Unihealth Consultancy IPO subscription opened on 08 Sep 2023, and closed on 12 Sep 2023
IPO allotment for Unihealth Consultancy was finalized on Friday, 15 Sep 2023
IPO listing for Unihealth Consultancy was on NSE on Thursday, 21 Sep 2023
Unihealth Consultancy IPO LISTING GAINS
| Issue Price (adjusted) | 132.0 |
| Listing Open Price | 135.0 |
| Listing Close Price | 133.0 |
| Listing Gain% | 2.3% |
| Current Gain% | 316.9% |
Unihealth Consultancy Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unihealth Hospitals Ltd. | 550.2 | 847.4 | 34.1 | 0.5 | 6.2 | 18.8 | 10.2 | 137 | 134.6 | 25.8 | 70.6 | 16.1 | 64.2 |
| Dr. Lal Pathlabs Ltd. | 1906.4 | 31998.7 | 59 | 10.5 | 11.1 | 20.1 | 16 | 2864.2 | 12.1 | 504.8 | 3.6 | 32.3 | 5.6 |
| Inventurus Knowledge Solutions Ltd. | 1703.8 | 29232.6 | 38.3 | 0.9 | 8.7 | 25.8 | 16.9 | 3209.5 | 18.7 | 721.6 | 48.4 | 44.5 | 40.9 |
| Sagility Ltd. | 42.1 | 19699 | 19.2 | 0.7 | 2.5 | 9.6 | 7.3 | 7290.8 | 29.6 | 924.8 | 71.5 | 2.2 | 28.5 |
| Vijaya Diagnostic Centre Ltd. | 1445.7 | 14890.4 | 79.4 | 3.2 | 17.4 | 18.1 | 11.5 | 835 | 19.3 | 173 | 20.9 | 18.2 | 24.9 |
| Molbio Diagnostics Ltd. | 1274 | 14681.6 | 14.2 | 7.8 | 1455.2 | 41.6 | 166.6 | 14.8 |
Annual
Balance Sheet
Ratios
Cash Flow
Unihealth Consultancy annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 |
|---|---|---|---|---|---|---|---|---|---|---|---|
52.8% | 92.5% | 13.2 | 6.9 | 6.6 | 3.7 | 2.6 | 0.5 | 1.4 | 0.7 | ||
Operating Exp. Ann. | 43.1% | 42.4% | 4.1 | 3.4 | 2.3 | 1.4 | 0.8 | 0.7 | 1.5 | 1.7 | |
Operating Profit Ann. | 60.9% | - | 2.5 | 0.2 | 2 | 0.6 | 0.8 | -0.1 | -1 | -1.6 | |
OPM Ann. % | 7.3% | - | 18.78% | 3.14% | 29.75% | 15.21% | 31.78% | -22.83% | -73.75% | -238.39% | |
19.2% | 22.4% | 4.4 | 3.7 | 2.8 | 2.6 | 2.1 | 1.6 | 2.5 | 2.5 | ||
EBITDA Ann. | 56.5% | - | 9.2 | 3.5 | 4.3 | 2.4 | 1.8 | -0.3 | -0.2 | -1.1 | |
EBITDA Ann. margin % | 3.1% | - | 69.34% | 51.28% | 65.23% | 63.35% | 68.69% | -51.45% | -12.57% | -154.66% | |
Interest Ann. | -56.3% | -34% | 0.1 | 0 | 0.3 | 1.2 | 1.2 | 0.8 | 0.9 | 0.6 | |
Depr. | 26% | 14.9% | 0.2 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | |
PBT Ann. | 100% | - | 8.8 | 3.2 | 3.8 | 1.1 | 0.5 | -1.2 | -1.2 | -1.9 | |
Tax Ann. | - | - | 2.3 | 0.9 | 0.8 | -0.2 | -0.1 | ||||
71% | - | 6.5 | 2.3 | 3 | 1.3 | 0.5 | -1.2 | -1.2 | -1.8 | ||
Net Profit Ann. | 71% | - | 6.5 | 2.3 | 3 | 1.3 | 0.5 | -1.2 | -1.2 | -1.8 | |
NPM Ann. % | 12.6% | - | 99.26% | 65.53% | 71.76% | 69.45% | 29.58% | -184.35% | -228.37% | -1,596.21% | |
EPS Adj. latest Ann. | 72.4% | - | 4.1 | 1.5 | 1.9 | 0.8 | 0.3 | -0.7 | -0.8 | -1.1 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
91.3%
2Y CAGR
41.4%
3Y CAGR
52.8%
5Y CAGR
92.5%
7Y CAGR
52.1%
Total Revenue Annual growth is stable compared to historical averages.
Net Profit Ann.
1Y CHG
182.6%
2Y CAGR
47.2%
3Y CAGR
71%
Net Profit Annual growth is stable compared to historical averages.
Operating Exp. Ann.
1Y CHG
20.6%
2Y CAGR
33.5%
3Y CAGR
43.1%
5Y CAGR
42.4%
7Y CAGR
13.4%
Operating Expenses Annual Cr growth is stable compared to historical averages.
Unihealth Consultancy INFORMATION ON IPO ISSUE
About Unihealth Consultancy
Unihealth Consultancy, established on February 26, 2010, is a healthcare service provider headquartered in Mumbai, India, with operational activities spanning several countries in Africa. The company operates across various business segments, encompassing medical centers, hospitals, consultancy services, distribution of pharmaceutical and medical consumable products, and medical value travel.
Object of the Issue
- Investment in the joint venture, Victoria Hospital Limited, Kampala, Uganda for funding its capital expenditure requirements for proposed expansion and working capital requirements
- Investment in the joint venture, UMC Global Health Limited, Nigeria for funding its capital expenditure requirements for the proposed expansion
- Investment in the subsidiary, Biohealth Limited, Tanzania for funding its capital expenditure requirements for the proposed expansion
- General corporate purposes
Unihealth Consultancy - PROMOTERS
| Name |
|---|
| Akshay Parmar |
| Anurag Shah |
Unihealth Consultancy Lead Manager to the Issue
Unistone Capital Private Limited
mb@unistonecapital.com
Unihealth Consultancy Registrar to the issue
Bigshare Services Private Limited
ipo@bigshareonline.com
Unihealth Consultancy Strengths
Focus on countries with a supply-demand gap
The company has strategically positioned medical centers and hospitals in countries characterized by a significant disparity between healthcare supply and demand. This approach enables it to serve populations that have been traditionally underserved and positively influence the healthcare services sector in these nations
Strength
Proof of concept
The company's current medical centres and hospitals, which it owns and manages, serve as tangible evidence of its expertise in healthcare project design, planning, and execution. These facilities demonstrate its capabilities and help potential clients build trust in its abilities
Strength
Growth opportunities and diversification
The company benefits from inherent strength derived from its access to the necessary infrastructure for expansion and the addition of new services, requiring minimal capital investments. This allows it to generate incremental revenues effectively
Strength
Unihealth Consultancy Risks
Interdependent businesses
The company's various businesses are interconnected, and any decline in one of the group's businesses can potentially have adverse effects on the overall performance of the company
Risk
Legal proceedings
The company is currently involved in certain legal proceedings, and if these proceedings are determined adversely, they may have an impact on the business and financial condition of the company
Risk
Competition
The hospital business operations in Uganda and Nigeria face competition from other hospitals and healthcare providers. The presence of competitors in the market poses a risk to the company's market share
Risk
IPO FAQs
The promoters of the company are Akshay Parmar and Anurag Shah.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 126.0 - 132.0.
The IPO application opens on Sep 08, 2023 and closes on Sep 12, 2023.
The minimum lot size for the IPO is 1000. The maximum lot size for the IPO is 1000.
For all category investors, the minimum application amount for this IPO is Rs. 132,000.0, the maximum value for this IPO is Rs 132,000.0.
This IPO will be allotted on Sep 15, 2023.
The refund will be credited to your account on Sep 18, 2023.
The allotted shares will be credited to your demat on Sep 20, 2023.
Unihealth Consultancy Ltd.’s shares listed on the stock exchanges on Sep 21, 2023.